← Open Payments lookup

HANNAH VANROOYEN: Open Payments

NPI 1497387518 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,672 in 99 payments from 20 companies in 2025. Trend: 2023 $1,399 · 2024 $1,826 · 2025 $1,672

Food & beverage: $1,672
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$248
Ardelyx, Inc.10$201
Takeda Pharmaceuticals U.S.A., Inc.14$199
Phathom Pharmaceuticals, Inc.20$193
ABBVIE INC.13$187
Regeneron Healthcare Solutions, Inc.5$110
Ipsen Biopharmaceuticals, Inc4$103
GENZYME CORPORATION3$87
Gilead Sciences, Inc.4$83
Janssen Biotech, Inc.2$42

Products named: XIFAXAN, IBSRELA, DUPIXENT, VOQUEZNA, ENTYVIO, IQIRVO, CREON, RINVOQ.

Industry payments across VA — which companies pay providers there.